跳至主要内容
临床试验/CTRI/2017/12/010920
CTRI/2017/12/010920已完成2 期

â??Clinical Evaluation of Haridradi Avleha and Virechana Karma in the Management of Tamaka Shwasa w.s.r. to Bronchial Asthmaâ??

ational Institute of Ayurveda0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients willing for trial and give consent.
  • 2.Patients of age group 18 to 60 years of either sex.
  • 3.Patients having signs and symptoms of Tamaka Shwasa (Bronchial asthma) as mentioned in Ayurvedic and Modern texts.
  • 4.Patients fit for Virechana Karma.

排除标准

  • 1.Patients not willing for trial.
  • 2.Age below 18 and above 60years of either sex.
  • 3.Patients suffering from Pulmonary Tuberculosis, Anaemia, Bronchus/Bronchogenic carcinoma, Chronic obstructive pulmonary disease, Pleural effusion.
  • 4.Status asthmaticus.
  • 5.Patients with rectal or vaginal prolapse.
  • 6.Pregnant and lactating women.
  • 7.Pateints suffering from serious systemic disorders like renal diseases, heart diseases, malignant hypertention, Diabetes Mellitus.Patients who are unfit for Virechana Karma.

研究者

相似试验